glp-1 receptor agonist antipsychotic weight gain study In a randomized clinical trial published in JAMA Psychiatry, a #GLP1 was assessed in patients with #Schizophrenia who were obese and had prediabetes. Over 30 weeks, semaglutide lowered glycosylated hemoglobin Alternate Club Health | flavor:60 Count trim

glp-1 receptor agonist antipsychotic weight gain study In a randomized clinical trial published in JAMA Psychiatry, a #GLP1 was assessed in patients with #Schizophrenia who were obese and had prediabetes. Over 30 weeks, semaglutide lowered glycosylated hemoglobin Alternate Club Health | flavor:60 Count trim

Alternate Club Health | TikTok

At each step in the shared decision-making process, clinicians need to identify a motivation for the patient to lose weight, according to Barbara Eichorst, MS, RD, CDCES, vice president of health care programs at the American Diabetes Association

trim

flavor:60 Count

Back Dushay, J (15 Sept 2023) 'How the Wegovy shortage is making life impossible for my patients — and for me', STAT News